Hartford Financial Management Inc. Has $1.17 Million Holdings in Baxter International Inc (NYSE:BAX)

Share on StockTwits

Hartford Financial Management Inc. lessened its holdings in shares of Baxter International Inc (NYSE:BAX) by 9.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,275 shares of the medical instruments supplier’s stock after selling 1,575 shares during the quarter. Hartford Financial Management Inc.’s holdings in Baxter International were worth $1,169,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in BAX. Weaver Consulting Group acquired a new position in shares of Baxter International in the first quarter valued at approximately $25,000. C J Advisory Inc acquired a new position in shares of Baxter International in the first quarter valued at approximately $28,000. Personal Wealth Partners acquired a new position in shares of Baxter International in the second quarter valued at approximately $29,000. TRUE Private Wealth Advisors acquired a new position in shares of Baxter International in the second quarter valued at approximately $29,000. Finally, Evolution Wealth Advisors LLC acquired a new position in shares of Baxter International in the second quarter valued at approximately $32,000. 83.96% of the stock is currently owned by hedge funds and other institutional investors.

In other news, Director John D. Forsyth sold 1,320 shares of the stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $78.21, for a total value of $103,237.20. Following the completion of the transaction, the director now directly owns 32,779 shares in the company, valued at approximately $2,563,645.59. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Jacqueline Kunzler sold 593 shares of the stock in a transaction on Wednesday, June 19th. The shares were sold at an average price of $80.46, for a total value of $47,712.78. Following the completion of the transaction, the senior vice president now owns 9,023 shares of the company’s stock, valued at $725,990.58. The disclosure for this sale can be found here. Insiders have sold 5,001,913 shares of company stock valued at $382,000,950 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Several research firms have recently commented on BAX. Cowen set a $75.00 target price on Baxter International and gave the company a “hold” rating in a research report on Monday, April 22nd. JPMorgan Chase & Co. upped their target price on Baxter International from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Monday, May 13th. BMO Capital Markets upped their target price on Baxter International to $95.00 and gave the company an “outperform” rating in a research report on Friday, July 26th. Royal Bank of Canada set a $87.00 target price on Baxter International and gave the company a “hold” rating in a research report on Friday, July 26th. Finally, Wells Fargo & Co set a $95.00 target price on Baxter International and gave the company a “buy” rating in a research report on Friday, July 26th. Four equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $85.27.

Shares of NYSE:BAX opened at $88.18 on Wednesday. The firm has a market capitalization of $44.09 billion, a P/E ratio of 28.91, a P/E/G ratio of 1.99 and a beta of 1.00. Baxter International Inc has a 1 year low of $61.05 and a 1 year high of $88.28. The company has a quick ratio of 2.10, a current ratio of 2.78 and a debt-to-equity ratio of 0.72. The business’s 50 day moving average is $83.32.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $0.89 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.81 by $0.08. The business had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.80 billion. Baxter International had a return on equity of 21.21% and a net margin of 14.28%. The firm’s quarterly revenue was down .1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.77 earnings per share. Sell-side analysts predict that Baxter International Inc will post 3.37 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 1st. Investors of record on Friday, August 30th will be given a dividend of $0.22 per share. This represents a $0.88 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date of this dividend is Thursday, August 29th. Baxter International’s dividend payout ratio is currently 28.85%.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

Featured Article: What is a Futures Contract?

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Pacific Sun Financial Corp Invests $247,000 in Union Pacific Co.
Pacific Sun Financial Corp Invests $247,000 in Union Pacific Co.
Pacific Sun Financial Corp Invests $427,000 in Invesco S&P 500 Equal Weight Technology ETF
Pacific Sun Financial Corp Invests $427,000 in Invesco S&P 500 Equal Weight Technology ETF
Pacific Sun Financial Corp Takes $407,000 Position in Invesco S&P 500 Pure Value ETF
Pacific Sun Financial Corp Takes $407,000 Position in Invesco S&P 500 Pure Value ETF
QCI Asset Management Inc. NY Buys 400 Shares of Analog Devices, Inc.
QCI Asset Management Inc. NY Buys 400 Shares of Analog Devices, Inc.
6,610 Shares in SPDR S&P Telecom ETF  Acquired by Pacific Sun Financial Corp
6,610 Shares in SPDR S&P Telecom ETF Acquired by Pacific Sun Financial Corp
Pacific Sun Financial Corp Purchases New Holdings in Invesco S&P 500 Low Volatility ETF
Pacific Sun Financial Corp Purchases New Holdings in Invesco S&P 500 Low Volatility ETF


© 2006-2019 Ticker Report